GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Arcoma AB (OSTO:ARCOMA) » Definitions » Enterprise Value

Arcoma AB (OSTO:ARCOMA) Enterprise Value : kr195.9 Mil (As of Jun. 10, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Arcoma AB Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Arcoma AB's Enterprise Value is kr195.9 Mil. Arcoma AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was kr11.1 Mil. Therefore, Arcoma AB's EV-to-EBIT ratio for today is 17.66.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Arcoma AB's Enterprise Value is kr195.9 Mil. Arcoma AB's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was kr19.5 Mil. Therefore, Arcoma AB's EV-to-EBITDA ratio for today is 10.04.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Arcoma AB's Enterprise Value is kr195.9 Mil. Arcoma AB's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was kr171.9 Mil. Therefore, Arcoma AB's EV-to-Revenue ratio for today is 1.14.


Arcoma AB Enterprise Value Historical Data

The historical data trend for Arcoma AB's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arcoma AB Enterprise Value Chart

Arcoma AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Enterprise Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 255.43 286.61 181.46 116.70 103.70

Arcoma AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 124.00 133.96 106.75 103.70 152.42

Competitive Comparison of Arcoma AB's Enterprise Value

For the Medical Devices subindustry, Arcoma AB's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Arcoma AB's Enterprise Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Arcoma AB's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Arcoma AB's Enterprise Value falls into.



Arcoma AB Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Arcoma AB's Enterprise Value for the fiscal year that ended in Dec. 2023 is calculated as

Arcoma AB's Enterprise Value for the quarter that ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Arcoma AB  (OSTO:ARCOMA) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Arcoma AB's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=195.934/11.092
=17.66

Arcoma AB's current Enterprise Value is kr195.9 Mil.
Arcoma AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr11.1 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Arcoma AB's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=195.934/19.525
=10.04

Arcoma AB's current Enterprise Value is kr195.9 Mil.
Arcoma AB's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr19.5 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Arcoma AB's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=195.934/171.891
=1.14

Arcoma AB's current Enterprise Value is kr195.9 Mil.
Arcoma AB's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr171.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Arcoma AB Enterprise Value Related Terms

Thank you for viewing the detailed overview of Arcoma AB's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Arcoma AB (OSTO:ARCOMA) Business Description

Traded in Other Exchanges
N/A
Address
Annavagen 1, Vaxjo, SWE, SE-352 46
Arcoma AB provides digital radiography systems in Sweden. It offers products including wireless flat panel detectors, positioning devices, and precision dr systems.

Arcoma AB (OSTO:ARCOMA) Headlines

No Headlines